Cargando…

Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients

Tumour acidosis contributes to cancer progression by inhibiting anti-tumour immunity. However, the effect of acidosis on anti-tumour T cell phenotypes in oesophageal adenocarcinoma (OAC) is unknown. Therefore, this study investigated the effect of acidosis on anti-tumour T cell profiles and if immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Davern, Maria, Donlon, Noel E., O’Connell, Fiona, Gaughan, Caoimhe, O’Donovan, Cillian, Habash, Mohammed, Sheppard, Andrew D., MacLean, Michael, Dunne, Margaret R., Moore, Jenny, Temperley, Hugo, Conroy, Melissa J., Butler, Christine, Bhardwaj, Anshul, Ravi, Narayanasamy, Donohoe, Claire L., Reynolds, John V., Lysaght, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813044/
https://www.ncbi.nlm.nih.gov/pubmed/35708739
http://dx.doi.org/10.1007/s00262-022-03228-y
_version_ 1784863846706446336
author Davern, Maria
Donlon, Noel E.
O’Connell, Fiona
Gaughan, Caoimhe
O’Donovan, Cillian
Habash, Mohammed
Sheppard, Andrew D.
MacLean, Michael
Dunne, Margaret R.
Moore, Jenny
Temperley, Hugo
Conroy, Melissa J.
Butler, Christine
Bhardwaj, Anshul
Ravi, Narayanasamy
Donohoe, Claire L.
Reynolds, John V.
Lysaght, Joanne
author_facet Davern, Maria
Donlon, Noel E.
O’Connell, Fiona
Gaughan, Caoimhe
O’Donovan, Cillian
Habash, Mohammed
Sheppard, Andrew D.
MacLean, Michael
Dunne, Margaret R.
Moore, Jenny
Temperley, Hugo
Conroy, Melissa J.
Butler, Christine
Bhardwaj, Anshul
Ravi, Narayanasamy
Donohoe, Claire L.
Reynolds, John V.
Lysaght, Joanne
author_sort Davern, Maria
collection PubMed
description Tumour acidosis contributes to cancer progression by inhibiting anti-tumour immunity. However, the effect of acidosis on anti-tumour T cell phenotypes in oesophageal adenocarcinoma (OAC) is unknown. Therefore, this study investigated the effect of acidosis on anti-tumour T cell profiles and if immune checkpoint blockade (ICB) could enhance anti-tumour T cell immunity under acidosis. Acidic conditions substantially altered immune checkpoint expression profiles of OAC patient-derived T cells, upregulating TIM-3, LAG-3 and CTLA-4. Severe acidosis (pH 5.5) significantly decreased the percentage of central memory CD4(+) T cells, an effect that was attenuated by ICB treatment. ICB increased T cell production of IFN-γ under moderate acidosis (pH 6.6) but not severe acidosis (pH 5.5) and decreased IL-10 production by T cells under severe acidic conditions only. A link between lactate and metastasis was also depicted; patients with nodal metastasis had higher serum lactate levels (p = 0.07) which also positively correlated with circulating levels of pro-angiogenic factor Tie-2. Our findings establish that acidosis-induced upregulation of immune checkpoints on T cells may potentially contribute to immune evasion and disease progression in OAC. However, acidic conditions curtailed ICB efficacy, supporting a rationale for utilizing systemic oral buffers to neutralize tumour acidity to improve ICB efficacy. GRAPHICAL ABSTRACT: Study schematic—PBMCs were isolated from OAC patients (A) and expanded ex vivo for 7 days using anti-CD3/28 +IL-2 T cell activation protocol (B) and further cultured for 48 h under increasing acidic conditions in the absence or presence of immune checkpoint blockade (nivolumab, ipilimumab or dual nivolumab + ipilimumab) (C). Immunophenotyping was then carried out to assess immune checkpoint expression profiles and anti-tumour T cell phenotypes (D). Serum lactate was assessed in OAC patients (E–F) and levels were correlated with patient demographics (G) and the levels of circulating immune/pro-angiogenic cytokines that were determined by multiplex ELISA (H). Key Findings—severe acidic conditions upregulated multiple immune checkpoints on T cells (I). Efficacy of ICB was curtailed under severe acidic conditions (J). Circulating lactate levels positively correlated with circulating levels of pro-angiogenic factor tie-2 and higher serum lactate levels were found in patients who had nodal metastasis (K). [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00262-022-03228-y.
format Online
Article
Text
id pubmed-9813044
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98130442023-01-06 Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients Davern, Maria Donlon, Noel E. O’Connell, Fiona Gaughan, Caoimhe O’Donovan, Cillian Habash, Mohammed Sheppard, Andrew D. MacLean, Michael Dunne, Margaret R. Moore, Jenny Temperley, Hugo Conroy, Melissa J. Butler, Christine Bhardwaj, Anshul Ravi, Narayanasamy Donohoe, Claire L. Reynolds, John V. Lysaght, Joanne Cancer Immunol Immunother Original Article Tumour acidosis contributes to cancer progression by inhibiting anti-tumour immunity. However, the effect of acidosis on anti-tumour T cell phenotypes in oesophageal adenocarcinoma (OAC) is unknown. Therefore, this study investigated the effect of acidosis on anti-tumour T cell profiles and if immune checkpoint blockade (ICB) could enhance anti-tumour T cell immunity under acidosis. Acidic conditions substantially altered immune checkpoint expression profiles of OAC patient-derived T cells, upregulating TIM-3, LAG-3 and CTLA-4. Severe acidosis (pH 5.5) significantly decreased the percentage of central memory CD4(+) T cells, an effect that was attenuated by ICB treatment. ICB increased T cell production of IFN-γ under moderate acidosis (pH 6.6) but not severe acidosis (pH 5.5) and decreased IL-10 production by T cells under severe acidic conditions only. A link between lactate and metastasis was also depicted; patients with nodal metastasis had higher serum lactate levels (p = 0.07) which also positively correlated with circulating levels of pro-angiogenic factor Tie-2. Our findings establish that acidosis-induced upregulation of immune checkpoints on T cells may potentially contribute to immune evasion and disease progression in OAC. However, acidic conditions curtailed ICB efficacy, supporting a rationale for utilizing systemic oral buffers to neutralize tumour acidity to improve ICB efficacy. GRAPHICAL ABSTRACT: Study schematic—PBMCs were isolated from OAC patients (A) and expanded ex vivo for 7 days using anti-CD3/28 +IL-2 T cell activation protocol (B) and further cultured for 48 h under increasing acidic conditions in the absence or presence of immune checkpoint blockade (nivolumab, ipilimumab or dual nivolumab + ipilimumab) (C). Immunophenotyping was then carried out to assess immune checkpoint expression profiles and anti-tumour T cell phenotypes (D). Serum lactate was assessed in OAC patients (E–F) and levels were correlated with patient demographics (G) and the levels of circulating immune/pro-angiogenic cytokines that were determined by multiplex ELISA (H). Key Findings—severe acidic conditions upregulated multiple immune checkpoints on T cells (I). Efficacy of ICB was curtailed under severe acidic conditions (J). Circulating lactate levels positively correlated with circulating levels of pro-angiogenic factor tie-2 and higher serum lactate levels were found in patients who had nodal metastasis (K). [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00262-022-03228-y. Springer Berlin Heidelberg 2022-06-16 2023 /pmc/articles/PMC9813044/ /pubmed/35708739 http://dx.doi.org/10.1007/s00262-022-03228-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Davern, Maria
Donlon, Noel E.
O’Connell, Fiona
Gaughan, Caoimhe
O’Donovan, Cillian
Habash, Mohammed
Sheppard, Andrew D.
MacLean, Michael
Dunne, Margaret R.
Moore, Jenny
Temperley, Hugo
Conroy, Melissa J.
Butler, Christine
Bhardwaj, Anshul
Ravi, Narayanasamy
Donohoe, Claire L.
Reynolds, John V.
Lysaght, Joanne
Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
title Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
title_full Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
title_fullStr Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
title_full_unstemmed Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
title_short Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
title_sort acidosis significantly alters immune checkpoint expression profiles of t cells from oesophageal adenocarcinoma patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813044/
https://www.ncbi.nlm.nih.gov/pubmed/35708739
http://dx.doi.org/10.1007/s00262-022-03228-y
work_keys_str_mv AT davernmaria acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT donlonnoele acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT oconnellfiona acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT gaughancaoimhe acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT odonovancillian acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT habashmohammed acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT sheppardandrewd acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT macleanmichael acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT dunnemargaretr acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT moorejenny acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT temperleyhugo acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT conroymelissaj acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT butlerchristine acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT bhardwajanshul acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT ravinarayanasamy acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT donohoeclairel acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT reynoldsjohnv acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients
AT lysaghtjoanne acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients